Trials / Completed
CompletedNCT00535639
Tolerability of ALK Tree Tablet
A Randomised, Multiple Dose, Dose Escalation, Double-Blind, Placebo-Controlled Phase I Study Investigating the Safety of ALK Tree Tablet in Adult Subjects With Birch Pollen Induced Rhinoconjunctivitis (With/Without Asthma).
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This trial is performed to assess the tolerability of the ALK Tree Tablet in patients with birch pollen induced allergy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betula Verrucosa allergen extract |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2007-12-01
- First posted
- 2007-09-26
- Last updated
- 2008-02-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00535639. Inclusion in this directory is not an endorsement.